Navigation Links
Concomitant treatment with nebulized formoterol fumarate & tio-significant improvements -- COPD
Date:5/20/2008

Napa, CA, (May 20, 2008) A newly published study presents data demonstrating that patients with Chronic Obstructive Pulmonary Disease (COPD), including emphysema and chronic bronchitis, experienced markedly improved bronchodilation and symptom control when treated with a combination of nebulized formoterol fumarate inhalation solution (Perforomist Inhalation Solution) and tiotropium (TIO), compared to treatment with tiotropium alone. The two medications, when used adjunctively, were also well tolerated by patients over the course of the 6-week study.

Concomitant Treatment with Nebulized Formoterol and Tiotropium in Subjects with COPD: A Placebo-Controlled Trial, published in Respiratory Medicine, assesses the efficacy and safety of the concomitant treatment of Perforomist nebulized formoterol fumarate (a long-acting β-agonist [LABA]) and tiotropium (an anticholinergic) in 130 adults with moderate to severe COPD.

These data provide additional insight into the additive benefit of concomitant therapy with a LABA and a long-acting anticholinergic, said Dr. Donald Tashkin, MD, FACP, FCCP, Professor of Medicine, David Geffen School of Medicine at the University of California at Los Angeles, lead author and principal investigator of the study. When Perforomist Solutions rapid onset of action is combined with tiotropiums prolonged bronchodilation, the result appears to be a safe and effective treatment option for patients. This is great news for the millions of patients and their families -- who live with COPD, and who too often struggle with an insufficient number of robust treatment options.

About the Study

The study was a six-week, randomized, double-blind, placebo-controlled, parallel-group design study. COPD patients entered a 7-14 day run-in period during which subjects received once-daily treatment with tiotropium bromide inhalation powder (TIO; Spiriva, 18 g) administered with a HandiHaler. Following r
'/>"/>

Contact: Amy Techtmann
amy.techtmann@fkhealth.com
617-761-6784
Feinstein Kean Healthcare
Source:Eurekalert

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. Clinical trial data: Safety/efficacy of concomitant formoterol fumarate/tiotropium treating COPD
2. New treatment effective in counteracting cocaine-induced symptoms
3. New treatment boosts muscle function in myasthenia gravis
4. Broad-based group of physicians calls for improvement in stroke treatment
5. Cranberry Could Juice Up Ovarian Cancer Treatment
6. Non-medicinal treatment touted for pre-schoolers with ADHD
7. Nonmedicinal treatment touted for preschoolers with ADHD
8. U of M study: Early treatment can reverse heart damage
9. Biologic treatment for rheumatoid arthritis and the risk of cancer
10. New Treatment Explored for Cluster Headaches
11. Thailand: Partners Open Free AIDS Treatment Clinic in Renowned AIDS Temple in Lop Buri
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/9/2010)... of remaining recurrence-free, research shows , , TUESDAY, Feb. ... are genetic profiles that play a part in prognosis ... depending on the age and gender of the patient. ... 787 patients who were divided into subgroups based on ... findings are published in the Feb. 10 issue of ...
(Date:2/9/2010)... vitamin D begins in the womb, expert says, , , ... mothers who drink lots of milk and have a ... a much lower risk of developing multiple sclerosis later ... 35,794 U.S. nurses whose mothers provided information about their ... for 16 years, and 199 of them developed multiple ...
(Date:2/9/2010)... low folic acid, high blood pressure restrict fetal growth, ... The lifestyle habits you bring into pregnancy can have ... , A Dutch study found that women who smoked, ... in early pregnancy had babies that were smaller in ... risk of complications later. , "Our study demonstrates that ...
(Date:2/9/2010)... Watchdog Also Warns Against Insurer-favored ,Cost Solution,: Selling Policies ... Apartment" ,, WASHINGTON , Feb. 9 ... for lawmakers and regulators with its premium hikes of ... Watchdog. In the face of questions from the White ... commissioner, federal and state lawmakers should act to regulate ...
(Date:2/9/2010)... The following statement is ... M.D., President, American Medical Association: ,, (Logo: ... Medical Association is pleased to support First ... Let,s Move Campaign. As the nation,s largest ... address obesity and are committed to reenergizing ...
Breaking Medicine News(10 mins):Health News:Genes Play Role in Prognosis With Non-Small Cell Lung Cancers 2Health News:Drinking Milk While Pregnant May Lower Kids' MS Risk 2Health News:Mom's Lifestyle in Early Pregnancy Affects Baby's Size 2Health News:Mom's Lifestyle in Early Pregnancy Affects Baby's Size 3Health News:Blue Cross Claim That 39% Premium Hikes Due Only to 'Escalating Cost of Health Care' Trigger Calls for Regulation of Rates 2Health News:Blue Cross Claim That 39% Premium Hikes Due Only to 'Escalating Cost of Health Care' Trigger Calls for Regulation of Rates 3
... (UNC) at Chapel Hill have revealed that inhaling hypertonic saline ... fibrosis (CF). Hypertonic saline// is a water-based salt solution ... arrived at this conclusion after testing 24 patients aged 14 ... salt solution improved the health of the lungs and the ...
... of the both wine and beer drinkers. It was found ... when compared to those of beer drinkers. This was attributed ... ,Morten Gr?nb?k, M.D., Ph.D. and colleagues of the Danish ... The researchers started to survey the items bought by ...
... Christopher Smith, Member of African Subcommittee, House Committee on ... house to house AIDS testing and counseling as done ... been found very effective in early diagnosis of HIV ... against HIV positive person due to ignorance about the ...
... A single tablet which is taken once a day for treating ... Squibb Co and Gilead Sciences Inc. The regimen of three drugs ... receive a formal approval towards end 2006. //As many as 40 ... poor nations accounting for most of the numbers. The US is ...
... of New Jersey (Rutgers) revealed that curry spice turmeric ... in the treatment of prostate cancer.// ... cress, broccoli, Brussels sprouts, kale, kohlrabi and turnips. ... combination is very effective in the treatment of prostate ...
... in for wholesome and healthy food, beer drinkers are attracted ... among// wine drinkers when compared to beer drinkers. Now ... have found that beer drinkers buy unhealthy food such as ... according to BBC News. ,Studying 3.5 million ...
Other Medicine News:Health News:Wine Drinkers Good Health, Attributed To Their Lifestyle 2
(Date:2/9/2010)... Feb. 9 LIVESTRONG Quarterly ... publication from LIVE STRONG .  The magazine features profiles ... resources and information about cancer prevention and treatment; and ... "As a three-time cancer survivor, I understand the worries ... said LIVE STRONG President and CEO Doug ...
(Date:2/9/2010)... Mass. , Feb. 9 Echo ... the needle-free Symphony™ tCGM System as a non-invasive, wireless, ... SkinPrep System for transdermal drug delivery, announced today that ... and CEO, will be interviewed on " Steve Crowley ... 9, 2010 at 9:34 AM ET ...
(Date:2/9/2010)... , Feb. 9 The rapid ... some shadow to the CRO and CMO businesses there. ... research and manufacturing organization that focuses on fine and ... advantages are not only low costs," said Dr. ... Shen continues: "What makes Chemphy so attractive to our ...
Breaking Medicine Technology:SPOT ON media and LIVESTRONG(R) Launch LIVESTRONG Quarterly 2SPOT ON media and LIVESTRONG(R) Launch LIVESTRONG Quarterly 3SPOT ON media and LIVESTRONG(R) Launch LIVESTRONG Quarterly 4Echo Therapeutics Chairman and CEO to be Interviewed on Steve Crowley's American Scene Radio Program and Featured on Money Channel Inc. 2Echo Therapeutics Chairman and CEO to be Interviewed on Steve Crowley's American Scene Radio Program and Featured on Money Channel Inc. 3Echo Therapeutics Chairman and CEO to be Interviewed on Steve Crowley's American Scene Radio Program and Featured on Money Channel Inc. 4DS Chemphy Focusing on CRO/CMO Business 2Pelosi Remarks at Democratic Steering and Policy Committee Forum on Health Insurance Reform 57234 1Pelosi Remarks at Democratic Steering and Policy Committee Forum on Health Insurance Reform 57234 2Pelosi Remarks at Democratic Steering and Policy Committee Forum on Health Insurance Reform 57234 3Sono Tek Announces its Largest Ever Sales of MediCoat Stent Coating Systems to a Leading Global Medical Device Manufacturer 57229 1Sono Tek Announces its Largest Ever Sales of MediCoat Stent Coating Systems to a Leading Global Medical Device Manufacturer 57229 2Disability Matters 3A Learn Your Rights Preserve Your Independence 57224 1Disability Matters 3A Learn Your Rights Preserve Your Independence 57224 2
... - Data Presented at 36th Child Neurology Society ... 11 PTC Therapeutics, Inc.,(PTC), a biopharmaceutical company ... drugs targeting,post-transcriptional control mechanisms, today announced pharmacokinetic,and safety ... PTC124 in patients with,Duchenne muscular dystrophy (DMD) due ...
... Conference Call Today at 9 am ET, ... NPSP ) today reported top-line results from,the ... GATTEX(TM),(teduglutide, recombinant GLP-2) in which 83 patients with ... of GATTEX, (0.05,milligrams/kilogram/day), a higher dose (0.10 mg/kg/day) ...
Other Medicine Technology:PTC Therapeutics Announces Pharmacokinetic and Safety Results from Phase 2 Study of PTC124 in Duchenne Muscular Dystrophy 2PTC Therapeutics Announces Pharmacokinetic and Safety Results from Phase 2 Study of PTC124 in Duchenne Muscular Dystrophy 3PTC Therapeutics Announces Pharmacokinetic and Safety Results from Phase 2 Study of PTC124 in Duchenne Muscular Dystrophy 4Clinical Benefits Demonstrated with Low-Dose GATTEX(TM) in Phase 3 Short Bowel Syndrome Study 2Clinical Benefits Demonstrated with Low-Dose GATTEX(TM) in Phase 3 Short Bowel Syndrome Study 3Clinical Benefits Demonstrated with Low-Dose GATTEX(TM) in Phase 3 Short Bowel Syndrome Study 4Clinical Benefits Demonstrated with Low-Dose GATTEX(TM) in Phase 3 Short Bowel Syndrome Study 5Clinical Benefits Demonstrated with Low-Dose GATTEX(TM) in Phase 3 Short Bowel Syndrome Study 6Clinical Benefits Demonstrated with Low-Dose GATTEX(TM) in Phase 3 Short Bowel Syndrome Study 7
ArcticTemp Upright Freezer -20C. Quick, even freezing. Heavy duty compressor. Deep door racks. Front gated bottom shelf. Interior light. Locks One year warranty on unit and 5 year warranty on compres...
... The F 265 is a highly accurate ... mV and temperature measurements. Temperature compensated pH results ... probe (ATC) or a 3-in-1 electrode. • This ... connect to a printer or a computer. Up ...
... swing doors, 12 shelves. Over-sized compressor. Triple ... interior lighting. Self-Contained System No plumbing required. ... Full One Year Warranty on Parts & Labor ... Also available as a chromatography unit ...
... 3 slide doors, 12 shelves.Over-sized compressor. ... Fluorescent interior lighting. Self-Contained System No plumbing ... Full One Year Warranty on Parts & ... Compressor. Also available as a chromatography ...
Medicine Products: